Rep. Julia Letlow (R-La.) has disclosed the sale of Bristol-Myers Squibb Company (BMY) common stock, according to a Periodic Transaction Report filed with the U.S. House of Representatives. The transaction was executed by the member of Congress herself on April 28, 2025, with the disclosed value falling between $1,001 and $15,000. The sale was made … Read more
Rep. Julia Letlow, who represents Louisiana in the U.S. House of Representatives, disclosed a purchase of Bristol-Myers Squibb Company Common Stock (BMY) in a Periodic Transaction Report filed under the STOCK Act. The report lists the transaction as a purchase made by Letlow herself, with a value falling between $1,001 and $15,000. According to the … Read more
Capital World Investors’s portfolio moves, tracked quarter by quarter. This profile follows the institutional investor’s Form 13F disclosures over time, giving a running record of new positions, exits, and adjustments as they are reported to the SEC. Because 13F filings only reveal a snapshot of holdings at quarter-end, this page will be refreshed with each … Read more
This page follows Sofinnova Investments, Inc.’s institutional portfolio as disclosed in its quarterly Form 13F filings with the SEC. A Form 13F is a required filing for institutional investment managers overseeing more than $100 million in U.S. equities, and it offers a snapshot of long positions held at the end of each quarter — not … Read more